Advertisement

Topics

Biodel, Inc. Company Profile

03:34 EDT 26th September 2017 | BioPortfolio

Biodel is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes. Biodel's product candidates are developed using technology which reformulates existing FDA-approved peptide drugs. For further information regarding Biodel, please visit the company's website at www.biodel.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012

DANBURY, Conn., May 7, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its second quarter fiscal year 2012 financial results on May 10, 2012.  Following the release of the company...

Biodel to Report Third Quarter Fiscal Year 2011 Financial Results on August 4, 2011

DANBURY, Conn., Aug. 1, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its third quarter fiscal year 2011 financial results on August 4, 2011.  Following the release of the company's ...

Biodel to Report First Quarter Fiscal Year 2012 Financial Results on February 8, 2012

DANBURY, Conn., Feb. 3, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its first quarter fiscal year 2012 financial results on February 8, 2012.  Following the release of...

Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas

DANBURY, Conn., July 26, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Biodel, Inc.

Biodel is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes. Biodel's produc...

Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes. Biodel's product candidates are develo...

More Information about "Biodel, Inc." on BioPortfolio

We have published hundreds of Biodel, Inc. news stories on BioPortfolio along with dozens of Biodel, Inc. Clinical Trials and PubMed Articles about Biodel, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biodel, Inc. Companies in our database. You can also find out about relevant Biodel, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...


Corporate Database Quicklinks



Searches Linking to this Company Record